Effect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD

Recruiting

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(1 site)

United States

Washington DC Veterans Affairs Medical Center (688), Washington D.C., District of Columbia